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Summary
Double-strand breaks (DSBs) are critical DNA lesions that robustly activate the elaborate DNA 
damage response (DDR) network. We identified a critical player in DDR fine-tuning - the E3/E4 
ubiquitin ligase, UBE4A. UBE4A’s recruitment to sites of DNA damage is dependent on primary 
E3 ligases in the DDR and promotes enhancement and sustainment of K48- and K63-linked 
ubiquitin chains at these sites. This step is required for timely recruitment of the RAP80 and 
BRCA1 proteins and proper organization of RAP80- and BRCA1-associated protein complexes at 
DSB sites. This pathway is essential for optimal end-resection at DSBs, and its abrogation leads to 
up-regulation of the highly mutagenic alternative end-joining repair at the expense of error-free 
homologous recombination repair. Our data uncover a critical regulatory level in the DSB response 
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and underscore the importance of fine-tuning of the complex DDR network for accurate and 
balanced execution of DSB repair.
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Introduction
Maintenance of genome stability is critical for cellular homeostasis, streamlined 
development, and prevention of undue cell death, cancer and premature aging. A major axis 
in maintaining genome stability is the DNA damage response (DDR), a broad network that 
activates DNA repair mechanisms and sets in motion an elaborate series of events that 
swiftly modulate numerous physiological processes (Goldstein and Kastan, 2015; Sirbu and 
Cortez, 2013). The highly cytotoxic double-strand break (DSB) provokes a robust and highly 
coordinated response of the DDR network (Goldstein and Kastan, 2015; Goodarzi and 
Jeggo, 2013; Shiloh and Ziv, 2013a; Sirbu and Cortez, 2013).
DSBs are repaired mainly by end resection-independent, canonical nonhomologous end-
joining (C-NHEJ), or resection-dependent homologous recombination repair (HRR) (Chang 
et al., 2017; Kowalczykowski, 2015). The predominant repair pathway is C-NHEJ, in which 
broken ends are processed and rejoined, operates throughout the cell cycle. HRR is based 
primarily on homologous recombination between the damaged DNA molecule and its intact 
sister, and therefore is active in the late S and G2 phases of the cell cycle. Minor resection-
dependent pathways are single-strand annealing (SSA), and alternative NHEJ (alt-NHEJ) 
(also referred to as microhomology-mediated end joining) (Chang et al., 2017). These 
pathways are based on annealing of sequences of different lengths in the 3’ overhangs 
generated by 5’ end-resection (Symington, 2016). While HRR is error-free, the other 
pathways are variably error-prone. A delicate balance between these repair pathways is 
essential for orderly completion of DSB sealing, and its abrogation may retard DSB repair 
and enhance genome aberrations (Shibata and Jeggo, 2014). Many players in the DSB 
response relocate to DSB sites, where they form large protein hubs (Lukas et al., 2011). 
These proteins typically undergo post-translational modifications (PTMs), primarily 
poly(ADP-ribosylation), phosphorylation, and modification by the ubiquitin family proteins, 
which set them up to operate in the DDR (Harding and Greenberg, 2016; Lee et al., 2017; 
Martin-Hernandez et al., 2017; Polo and Jackson, 2011; Shiloh and Ziv, 2013a; Wilson and 
Durocher, 2017). This massive protein recruitment is a highly structured process, in which 
the damage-induced PTMs often establish interactions among the proteins to help mobilize 
and correctly locate the next-in-line recruits. Interference with this process usually leads to 
abrogation of DSB repair. The chief transducer of the signal emanating from the DSB sites 
is the protein kinase, ATM, which phosphorylates a plethora of substrates at these sites and 
elsewhere (Paull, 2015; Shiloh and Ziv, 2013b).
Protein ubiquitylation at DSB sites is carried out by several E3 ubiquitin ligases and is 
critical for mobilizing chromatin dynamics at these sites, appropriate recruitment of DDR 
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factors and, eventually, DSB repair (Harding and Greenberg, 2016; Lee et al., 2017). Indeed, 
extensive K48- and K63-linked ubiquitylations were observed at DSB sites (Lee et al., 2017; 
Meerang et al., 2011), but the number of documented ubiquitylation targets is limited and 
current consensual substrates are histones H2A, H2B and H1 (Harding and Greenberg, 2016; 
Lee et al., 2017). Identification of the ubiquitin ligases that take part in the DDR is key to 
understanding ubiquitin-driven pathways in this network. Major factors in H2A 
ubiquitylation are the E3 ligases, RNF8 and RNF168, whose activity is required for proper 
recruitment of the 53BP1 protein – a platform for additional DDR proteins and a regulator of 
DSB repair pathway choice – and RAP80, which anchors the protein complex, BRCA1-A, 
whose subsequent dynamics plays a role in the critical balance between DSB repair 
pathways (Lombardi et al., 2017).
Among the various families of E3 ubiquitin ligases, a small subgroup of the RING-type 
ligases contains a modified RING domain called U-box, which, like the RING domain, is 
essential for the enzyme’s catalytic activity (Aravind and Koonin, 2000). One of the best 
characterized U-box ligases is the yeast protein, ubiquitin-fusion degradation 2 (Ufd2), 
which has been associated with endoplasmic-reticulum-associated protein degradation 
(ERAD) (Johnson et al., 1995). Ufd2 also possesses an E4 ligase activity. E3 ligases with E4 
activity (E3/E4 ligases) can bind to a single conjugated ubiquitin or an oligoubiquitin chain 
generated by other E3 ligases and further extend and regulate the lengths of the chains 
(Hatakeyama et al., 2001; Hoppe, 2005). Ufd2 is conserved throughout evolution, with two 
orthologs in mammals that are likely paralogs, designated in humans UBE4A and UBE4B. 
UBE4B’s E4 ligase activity has been demonstrated, and among its substrates are p53 and 
ataxin-3 (Du et al., 2015; Hatakeyama and Nakayama, 2003; Matsumoto et al., 2004; Park et 
al., 2008, 2009; Periz et al., 2015; Starita et al., 2013; Wu and Leng, 2011; Wu et al., 2011). 
UBE4A’s activity and physiological significance have not been extensively documented. 
Recently it has been implicated in targeting interleukin-like EMT inducer for degradation 
(Sun et al., 2017).
Here, we show that UBE4A is a critical DDR factor. It has an E4 ubiquitin ligase activity in 
vitro, and in cells its presence is required for tweaking the extent of both K48- and K63-
linked ubiquitin chains at sites of DNA damage. Acting downstream of the primary E3 
ligases in the DDR and 53BP1, UBE4A’s action in fine adjustment of ubiquitin chain length 
is required for proper internal organization of DSB-associated protein foci, and ultimately 
for maintaining the exquisite balanced between DSB repair pathways and timely DSB repair.
Results
UBE4A is essential for appropriate cellular response to DSBs
Our attention was drawn to UBE4A and UBE4B when UBE4B was identified as a hit in a 
functional screen we carried out in search of novel determinants of ubiquitylation in the 
DDR (Figure S1 and Supplemental Information). In view of their sequence similarity, we 
explored the possibility that both proteins are involved in the DDR. Initial experiments 
indicated that this was the case, but UBE4A and UBE4B seemed to function separately in 
different DDR branches. Here, we focus on UBE4A, the less studied paralog (Figure 1A). 
First indication that UBE4A functions in the DSB response came from the observation that 
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its depletion led to cellular hypersensitivity to the radiomimetic drug, neocarzinostatin 
(NCS), in a clonogenic survival assay (Figure 1B). Such sensitivity is suggestive of defective 
DSB repair. In order to directly examine the effect of UBE4A depletion on DSB sealing, we 
used the sensitive neutral comet assay (Glei et al., 2016) to measure the amount of DSBs 
remaining in genomic DNA after treatment with ionizing radiation (IR). Significant 
differences in comet tail moment (an actual measure of DSBs in the neutral comet assay) 
were observed between UBE4A-proficient and -depleted cells 24 hr after IR treatment 
(Figure 1C), indicating a marked, continuous retardation in DSB closure upon reduction of 
UBE4A level. Similarly, UBE4A depletion led to retarded disappearance of nuclear foci of 
the DDR protein, 53BP1, 24 hr after treatment with NCS (Figure 1D). Importantly, ectopic 
expression of wild-type UBE4A in cells depleted of the endogenous protein complemented 
the defective repair phenotype, while a potentially inactive mutant protein lacking the U-box 
failed to do so (Figure 1D), suggesting that the catalytic activity of UBE4A is essential for 
its function in DSB repair.
UBE4A is recruited to sites of DNA damage, dependent upon major E3 ligases in the DDR, 
and 53BP1
A common attribute of many DSB response players is their temporary relocation to the 
damage sites. In view of the above results we asked whether UBE4A undergoes such 
relocation. The dynamics of this recruitment is usually monitored after induction of 
localized DNA damage in a narrow nuclear sector using a focused laser microbeam. We 
observed relocalization to such “laser stripes” of a portion of ectopic, GFP-tagged UBE4A 
within minutes of damage induction (Figure 2A). Mutant protein lacking the U-box was 
recruited at similar kinetics (Figure 2A), indicating that UBE4A’s catalytic activity was not 
required for this process. We further demonstrated UBE4A’s recruitment to damage sites by 
following the relocation of endogenous UBE4A to ‘laser stripes’, using a specific antibody 
(Figure 2B). The data thus establish that UBE4A is part of the large cohort of proteins that 
function at DSB sites and are required for efficient DSB repair.
The formation of the protein hubs spanning DSBs is a structured, hierarchical process, and 
the precise order of protein relocalization to the break sites reflects the dependence of each 
protein’s recruitment on previously recruited ones. In order to place UBE4A in this 
hierarchy, we examined the dependence of its recruitment on selected proteins in the 
cascade. Out of this list, depletion of 53BP1 and the E3 ubiquitin ligases, RNF8 and 
RNF168, markedly affected UBE4A recruitment, and depletion of the E3 ligase, RNF4, 
moderately reduced it (Figures 2C, S2A, B). These E3 ligases drive a major ubiquitylation 
cascade at DSB sites that is essential for DSB repair. Thus, our results suggest that timely 
appearance of UBE4A at the damage sites depends on prior protein ubiquitylation at these 
sites, and on prior presence at these sites of 53BP1 – a central regulator of the choice 
between DSB repair pathways (Daley and Sung, 2014; Gupta et al., 2014).
The yeast ortholog of UBE4A and UBE4B – Ufd2 – functions in close collaboration and 
physical association with the ATPase, Cdc48, and with the Rad23 protein (Baek et al., 
2013). The human ortholog of Cdc48, p97/VCP, was recently reported to play a role in the 
DSB response (Torrecilla et al., 2017). The mammalian paralogs of Rad23, RAD23A and 
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RAD23B are involved in the response to bulky DNA lesions via the nucleotide excision 
repair pathway (Yokoi and Hanaoka, 2017). We therefore examined the possible dependence 
of UBE4A’s recruitment to damage sites on these proteins. We found that RAD23A, 
RAD23B and VCP were not required for UBE4A recruitment to damage sites; nor was 
UBE4A’s paralog, UBE4B, necessary for this process (Figures 2C, S2A, C). Furthermore, 
depletion of UBE4A did not affect the recruitment of the DDR proteins, RNF8, RNF168, 
53BP1, and MDC1, or γH2AX formation (Figure S2D). These experiments place UBE4A at 
a relatively late stage in the hierarchy of protein assembly at DSB sites, with dependence on 
prior protein ubiquitylation within these protein assemblies and downstream of 53BP1. 
Interestingly, we found that UBE4A co-immunoprecipitates with 53BP1 and this co-
immunoprecipitation is enhanced by DNA damage (Figure S3). This observation and the 
53BP1 dependence of UBE4A recruitment suggest that UBE4A’s entry into the DSB 
response cascade is mediated at least in part by direct or indirect interaction with 53BP1.
UBE4A activity and UBE4A-dependent modulation of K48- and K63-linked ubiquitin chains 
at damage sites
We assumed that UBE4A functions at DSB sites in its capacity as an E4 ubiquitin ligase, an 
activity that was previously demonstrated in its paralog, UBE4B. In order to demonstrate 
UBE4A’s E4 activity, we carried out an experiment similar to a previous one that showed 
UBE4B’s E4 activity in vitro (Park et al., 2009). The UFD pathway can be probed in cells 
and in vitro using an artificial substrate, monoubiquitylated GFP (Dantuma et al., 2000). 
Using such substrate, in which the ubiquitin moiety is mutated and thus uncleavable 
(UbG76V), the Yoon lab previously found that the HECT domain E3 ligase, TRIP12, 
functions in the UFD pathway in mammalian cells, but for optimal ubiquitylation of the 
substrate, TRIP12’s activity should be followed by the E4 activity of UBE4B (Park et al., 
2009). This requirement for both the E3 and E4 ligases for optimal substrate ubiquitylation 
was demonstrated in vitro (Park et al., 2009). In an analogous experiment we used the same 
in vitro system, only with UBE4A as the E4 ligase (Figures 3, S4). We found that, similarly 
to its paralog, UBE4B (Park et al., 2009), UBE4A functions in this reaction as an E4 ligase. 
Further evidence for UBE4A’s involvement in protein ubiquitylation in cells was obtained 
by examining the effect of its depletion on cellular protein ubiquitylation using a method 
developed recently to pull down ubiquitylated proteins from cellular extracts (Sims et al., 
2012). According to this method, ubiquitin-interacting domains (UIMs) are expressed in 
cells and are subsequently immunoprecipitated using an attached tag that pulls down 
interacting proteins. We used a construct containing 3 tandem UIMs derived from the DDR 
protein, RAP80, which selectively bind K63-linked ubiquitin chains (Sims et al., 2012; 
Thorslund et al., 2015). Indeed, UBE4A depletion decreased the amount of K63-linked 
ubiquitylation in unirradiated and X-irradiated cells (Figure S5), suggesting a role for 
UBE4A in shaping protein ubiquitylation in cells in several ubiquitin-driven processes, 
similarly to its paralog UBE4B.
The E4 ligase function is plausibly broad and used in various physiological contexts. 
Accordingly, E3/E4 ligases have broad specificity with regard to the types of ubiquitin 
chains they extend, which may depend on the combinations of E2 and E3 ligases in specific 
reactions (Ackermann et al., 2016; Hatakeyama and Nakayama, 2003; Hoppe, 2005; Liu et 
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al., 2017; Matsumoto et al., 2004; Park et al., 2008, 2009; Saeki et al., 2004; Wu and Leng, 
2011; Wu et al., 2011). UBE4B was shown to extend K27-, K33- and K48-linked chains 
(Hatakeyama and Nakayama, 2003; Hatakeyama et al., 2001; Park et al., 2008, 2009; Wu 
and Leng, 2011; Wu et al., 2011). Yeast Ufd2 catalyzes the extension of K29- and K48-
linked chains (Ackermann et al., 2016; Saeki et al., 2004) and creates branched chains by 
catalyzing K48-linked multi-monoubiquitylation on K29-linked ubiquitin chains (Liu et al., 
2017). C. elegans Ufd-2 extends K29- and K48-linked chains (Ackermann et al., 2016) as 
well as K63-linked chains (Wojtek Pokrzywa and Thorsten Hoppe, unpublished). DSB sites 
are characterized by extensive K48- and K63-linked protein ubiquitylation (Meerang et al., 
2011; Ramadan, 2012). We asked whether UBE4A was involved in extending these chain 
types at sites of DNA damage. Previous work showed that K48-linked ubiquitylation at 
damage sites mounts rapidly, peaks 15 min after damage induction, and decreases sharply 
within the next hour, while K63-linked ubiquitylation peaks 1 hr after damage induction and 
persists for several hours (Meerang et al., 2011; Ramadan, 2012). These experiments were 
based on quantitating the signal obtained at laser stripes after immunostaining with 
antibodies specific for these ubiquitin chain types. Cells depleted for the p97/VCP protein 
serve as controls in these experiments, since loss of this protein leads to excessive 
accumulation of ubiquitylated proteins at damage sites (Meerang et al., 2011).
We quantified the average intensity of K48- and K63-linked ubiquitylation at DNA damage 
sites using antibodies specific for these chain types (Figure S6). UBE4A depletion markedly 
decreased but did not eliminate the average K48 signal 15 min after damage induction, and 
the effect was diminished 2 hr later, when the K48 signal usually subsided (Figures 4A, B, 
S7A). When we classified the ubiquitin signals as ‘strong’, ‘average’ and ‘undetectable’ 
(Figure S7B), cells depleted of UBE4A had a significantly lower fraction of ‘strong’ K48 
stripes and higher fraction of ‘undetectable’ stripes 15 min after damage induction, 
compared to siCTRL-treated cells (Figure 4C). This implies that UBE4A is important for 
timely formation of K48-linked ubiquitin chains in proper amounts at the sites of DNA 
damage. Quantifying the intensity of K63-linked chains at the sites of DNA damage showed 
that depletion of UBE4A led to lower average intensity of these chains relative to the 
control, both 15 min and 2 hr after induction of DNA damage (Figures 4D, E, S7C). 
Accordingly, UBE4A depletion led to a markedly higher fraction of cells with undetectable 
K63-linked chain signals at damage sites compared to siCTRL, and a lower fraction of 
average and strong intensity chain signals (Figure 4F). Taken together, these data establish 
that UBE4A is critical for the required timing and amount of two major types of 
ubiquitylation that occur ubiquitously at sites of DNA damage: K48-linked ubiquitylation, 
which marks target proteins for proteasome-mediated degradation, and K63-linked chains, 
which alter protein function or mode of action (Spasser and Brik, 2012; Williamson et al., 
2013).
UBE4A is required for complete assembly of specific DDR factors at DSB sites and proper 
internal organization of DSB-associated protein foci
An important outcome of K63-linked ubiquitylation at DSB sites is the recruitment of the 
DDR factors, RAP80, which has specific affinity to these ubiquitin chains due to its tandem 
ubiquitin-interacting motifs (Lombardi et al., 2017). Indeed, UBE4A depletion led to 
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reduced accrual of RAP80 at DNA breaks (Figure 5A) in a manner that was dependent on 
UBE4A activity (Figure 5B). A further consequence of UBE4A depletion was reduced 
recruitment of BRCA1, which is dependent on RAP80 (Figure 5C). RAP80 recruitment was 
not completely abolished, however, since UBE4A depletion does not completely eliminate 
protein ubiquitylation at damage sites (Figure 4). Further downstream is the major HRR 
protein, RAD51, and here too damaged UBE4A-depleted cells exhibited a significantly 
lower number of nuclear RAD51 foci at the S and G2 cell cycle phases (in which HRR 
functions) (Figure 5D).
Once these proteins are recruited to DSB sites their precise assembly there in space and time 
and the dynamics of the internal focus organization are critical for proper DSB repair (Lukas 
et al., 2011). In order to study this organization we used single-molecule localization-based 
super-resolution (SR) imaging, a powerful form of fluorescent microscopy that offers a ten-
fold improvement over conventional diffraction-limited microscopy, such as confocal 
microscopy (Huang et al., 2009). The modality was recently used to examine the 
organization of DSB repair proteins at damage sites (Conlin et al., 2017; Reid et al., 2015) 
(See Figures 6A, B for examples). To generate SR images, we used direct Stochastic Optical 
Reconstruction Microscopy (dSTORM) to localize single-fluorescent dye molecules below 
the diffraction limit (van de Linde et al., 2011). In dSTORM, fluorescent dyes are 
predominately in a dark state (not fluorescing) due to the presence of the chemical 
mercaptoethylamine (MEA). However, at any given time a small, sparse, subset of 
fluorophores emits fluorescence, permitting their localization. This population changes 
stochastically, and by acquiring a series of images from a viewing field, a super-resolved 
image can be generated with coordinates of each localized molecule. The Rothenberg and 
other groups recently used this approach to study the structure of DNA damage-associated 
protein foci (Britton et al., 2013; Doksani et al., 2013; Reid et al., 2015; Young et al., 2015), 
as well as other systems that challenge imaging due to a size that is close to the diffraction 
limit, such as neuronal synapses (Dani et al., 2010). Moreover, since single dyes are 
localized, this technique is substantially more sensitive than other super-resolution 
techniques so analysis is not necessarily confined to the brightest foci. Here, the information 
obtained allows us to make quantitative determinations, such as the area occupied by various 
proteins (Wani et al., 2016) that might be missed with conventional imaging. In addition we 
can measure the degree of overlap between proteins (Figures 6A, B) yielding information 
about the spatial organization and physical proximity among proteins within the focus. 
These parameters may point to the intactness of the processes in which these protein 
function. Since UBE4A depletion affected the recruitment of RAP80, BRCA1, and RAD51 
(Figure 5), we focused on these proteins as well as two other HRR factors, BRCA2 and 
PALB2.
RAP80 mediates the recruitment of the BRCA1-A complex, which includes BRCA1, 
RAP80, ABRAXAS, and MERIT40 and antagonizes HRR (Coleman and Greenberg, 2011). 
This barrier to HRR is subsequently removed during spreading and repositioning of the 
BRCA1-A complex and the formation of the BRCC complex, which includes BRCA1, 
BRCA2, PALB2 and RAD51 and drives HRR [reviewed by (Park et al., 2014)]. Notably, the 
spatial distribution of RAP80 foci determined here using dSTORM (~0.3-0.4 micron2; Fig. 
S8) was similar to that previously reported using correlative light and electron microscopic 
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imaging of γH2AX foci (Dellaire et al., 2009). We also found that, compared to controls, 
the areas occupied by RAP80 and BRCA1 were larger in UBE4A-depleted cells at early 
time points (5-30 min after damage induction), and returned to normal values 6 hr later 
(Figures 6C-E, S8A, B). On the other hand, the areas occupied by BRCA2 and PALB2 after 
UBE4A depletion were smaller than in control cells (Figure 6C). Accordingly, UBE4A 
depletion led to increased overlaps of RAP80 and BRCA1 with γH2AX, and decreased 
these overlaps for BRCA2, PALB2 and RAD51 (Figures 6D, E). The results suggested that 
UBE4A depletion caused increased presence of the BRCA1-A complex and reduced 
presence of the BRCC complex at the early time points after DSB induction, which could 
lead a-priori to reduced HRR. Taken together, the results show that the recruitment of 
UBE4A downstream of 53BP1 and its E4 ligase activity are required for shaping up the 
protein ubiquitylation at DSB sites essential to optimal buildup of the protein array required 
for HRR (Figure 6F). We therefore proceeded to examine the interplay between DSB repair 
pathways upon UBE4A depletion.
A shift from HRR to alt-NHEJ upon UBE4A depletion
HRR – the only error-free pathway – was evaluated in UBE4A-depleted cells using two 
different assays. The extensively documented DR-GFP reporter provides a fluorescent 
readout of HRR that takes place at a break induced by the restriction enzyme I-SceI (Pierce 
et al., 2001). This assay showed moderate reduction in HRR upon UBE4A depletion (Figure 
7A). A recently developed system for measuring the efficiency of homology-directed repair 
(HDR) is the CRISPR-LMNA HDR assay (Pinder et al., 2015) (Figure S9). In this assay, a 
Cas9-generated DSB at the LMNA gene locus is repaired using a DNA homology donor 
encoding the green fluorescent protein, Clover, flanked by homology to the endogenous 
LMNA locus. Successful HDR between the homology donor and the LMNA locus results in 
expression of Clover-tagged LMNA and green fluorescence at the nuclear lamina. Depletion 
of UBE4A significantly reduced the efficiency of CRISPR-mediated HDR, by 40% 
compared to an irrelevant siRNA, whereas a 70% reduction in HDR was conferred by 
depletion of a major HRR factor, RAD51 (Figure 7B). In parallel, we measured the effect of 
UBE4A depletion on C-NHEJ, alt-NHEJ and SSA, as well as the extent of end-resection at 
DSBs. Importantly, while C-NHEJ and SSA were not affected, alt-NHEJ was increased in 
UBE4A-depleted cells (Figures 7C-E). End-resection – a key apical process in the decision 
among DSB repair pathways – was moderately reduced upon UBE4A depletion (Figure 7F). 
These results suggest that, following UBE4A depletion, end-resection becomes suboptimal 
and resection intermediates that cannot serve as HRR starting points are channeled to the 
highly error-prone alt-NHEJ (Figure 7G). Such shift in the balance between repair pathways 
is also likely to leave unrepaired breaks (Figure 1C). Thus, the UBE4A-dependent pathway 
culminates in the exquisite regulation of the balance among DSB repair pathways.
Discussion
The DSB response is an intricate, multi-level operation, and the activity within the massive 
protein hubs that form around DSBs attests to a highly complex cascade of events. Despite 
the complexity, this is a fine-tuned process that brings each DDR protein to the protein 
conglomerates spanning DSB sites at the precise time and location to perform the ultimate 
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task: smooth and streamlined DSB repair. The importance of tight regulation of protein 
ubiquitylation in this process has been noted (Harding and Greenberg, 2016; Lee et al., 
2017; Panier and Durocher, 2013). A primary level of this regulation is the universal balance 
between the relevant E3 ligases and opposing deubiquitylating proteases (DUBs) (Pellegrino 
and Altmeyer, 2016). Interestingly, the DUBs USP26 and USP27 were found to modulate 
RNF168-mediated protein ubiquitylation at DSB sites thereby preventing excessive 
spreading of RAP80-BRCA1, promoting association of BRCA1 with PALB2 and 
streamlining HRR (Typas et al., 2015), similarly to the role we attribute to UBE4A. Another 
level of regulation is mediated by opposing actions of E3 ligases. The E3 ligase, RNF169, 
was found to be recruited to DSB sites in an RNF8/RNF168-dependent manner and 
attenuate ubiquitin-mediated signaling and accumulation of 53BP1 and RAP80 at damaged 
chromatin, thereby stimulating HRR and restraining NHEJ (Chen et al., 2012; Poulsen et al., 
2012). RNF168 recruitment itself was found to be modulated by two other E3 ligases, 
TRIP12 and UBR5 (Gudjonsson et al., 2012).
Here, we add another control layer to this cascade: the careful regulation of the extent of 
protein ubiquitylation at the damage sites by an E3/E4 ubiquitin ligase, UBE4A. Recently, 
(Ackermann et al., 2016) reported that in C. elegans UFD-2 was involved in the DDR in the 
worm’s gonad, in a different capacity than that of UBE4A’s role in the DSB response 
reported here. In that organism, the E3/E4 ligase plays a role in the decision between cell 
survival and apoptosis following induction of DNA damage. Despite the different pathways, 
the work of Ackerman et al. (2016) and our data indicate that meticulous shaping of 
ubiquitin chains by an E3/E4 ligase is essential for proper DDR throughout evolution.
Our mechanistic insight into the actual role of UBE4A-mediated ubiquitylation highlights 
the tight regulation of the balance between DSB repair pathways. Our data demonstrate that 
this fine-tuned regulatory system is abrogated in the absence of UBE4A, as a result of 
improper accumulation and organization at DSB sites of its components. This ultimately 
leads on one hand to retarded formation of the BRCC complex that is necessary for HRR, 
and on the other hand – to incomplete end-resection at DSB sites – another critical step in 
the HRR pathway. Subsequently, the resection intermediates are used by the highly error-
prone alt-NHEJ pathway, rather than the error-free HRR (Figure 7G). Both HRR and alt-
NHEJ rely on end-resection, and the extent of this critical step in DSB repair is subject to 
stringent regulation (Symington, 2016). Because HRR requires longer single-stranded 3’ 
overhangs, it is plausible that insufficiently resected overhangs will serve as alt-NHEJ 
substrates. Indeed, HRR deficiency due to deletions of RAD51 or RAD52 in yeast elevates 
alt-NHEJ (also called MMEJ) (Deng et al., 2014; Villarreal et al., 2012), and alt-NHEJ is 
elevated in human cells following BRCA1 elimination (Yun and Hiom, 2009).
The emerging picture is one of successive action of E3 ligases followed by an E3/E4 ligase, 
collectively shaping carefully and meticulously the ubiquitylation landscape around the 
break site. The exact sculpting of this landscape is essential for accurate protein dynamics 
and subsequent DSB repair. This process is intolerant of even the slightest perturbation, 
which can cause delayed or aberrant DSB repair, either of which may result in genomic 
rearrangements. The sophisticated regulation of the DDR and the absolute requirement of 
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every last one of its components explain why mutations that affect any one of them can lead 
to grave phenotypic outcomes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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1. UBE4A depletion affects DSB repair.
(A) Domain diagram of UBE4A. (B) UBE4A depletion leads to cellular hypersensitivity to 
the radiomimetic chemical, NCS. Clonogenic survival curves of CAL51 cells transfected 
with control siRNA (siCTRL) or two siRNAs directed against UBE4A and subsequently 
treated with various NCS doses. siCTRL cells and cells transfected with siATM served as 
controls. The immunoblot shows the degree of protein depletion for UBE4A and ATM. (C) 
Direct observation of DSBs in UBE4A-proficient and depleted A549 cells using a neutral 
comet assay, 1 and 24 hr after irradiation with 10 Gy of IR. (D) Numbers of 53BP1 nuclear 
foci in cells 24 hr after treatment with 20 ng/ml of NCS. Cells were transfected with the 
indicated siRNAs and with vectors expressing GFP or siRNA-resistant cDNAs encoding 
GFP-tagged wild-type UBE4A or mutant UBE4A lacking the U-box (GFP-UBE4AΔU-box). 
The immunoblot shows the extents of endogenous UBE4A depletion and expression of 
ectopic proteins.
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Figure 2. UBE4A relocalizes to sites of DNA damage dependent upon other E3 ligases and 
53BP1.
(A) Dynamics of UBE4A relocalization to damage sites in live cells. Cells were depleted of 
endogenous UBE4A using RNAi and co-transfected with vectors expressing siRNA-resistant 
cDNAs of GFP-UBE4A or GFP-UBE4AΔU-box, together with DsRed2-tagged 
polynucleotide kinase-phosphatase (PNKP). The rapid recruitment of PNKP to damage sites 
(red) (Segal-Raz et al., 2011) marks their location. Localized DNA damage was induced 
using a focused laser microbeam and the cells were monitored by time-lapse imaging. Note 
the rapid recruitment to laser-induced damage sites of both wild-type and mutant UBE4A 
(green). (B) Recruitment of endogenous UBE4A to sites of laser-induced damage. Cells 
were transfected with siRNA against UBE4A or irrelevant siRNA, treated with laser 
microirradiation, and immunostained 40 min later with antibodies against UBE4A and 
γH2AX. (C) Using the same experimental setup as in (B), the cells were transfected with 
the indicated siRNAs, treated with laser microirradiation, and monitored for recruitment of 
endogenous UBE4A to damage sites 20 min later. The fraction of γH2AX stripes co-stained 
for UBE4A was recorded and is presented in the upper panel as mean ± SD (3 independent 
experiments, n=200). *p<0.05, ***p<0.0005 (student’s t-test). (See also Figure S2).
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Figure 3. E4 ligase activity of UBE4A in vitro.
(A) His6-UbG76V-GFP (300 ng) was incubated for 1h at 37 °C with FLAG-TRIP12 (200 and 
400 ng in lanes 2 and 3, respectively, and 800 ng in lanes 4-6) and FLAG-UBE4A (250 and 
500 ng in lanes 5 and 6, respectively, and 1000 ng in lanes 1 and 7) in a reaction mixture 
containing 2 mM ATP, 800 ng of His6-Ub, 100 ng of His6-Uba1, 250 ng of His6-UbcH5a. 
The reaction was terminated by addition of 2X Laemmli sample buffer and subjected to 
SDS-PAGE. The blot was subsequently probed with an anti-GFP antibody. (B) Similar 
reactions as in (A) with another E3 ligase, E6AP, replacing TRIP12. (See also Figure S4).
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Figure 4. UBE4A is required for timely and quantitatively proper assembly of ubiquitin chains at 
sites of DNA damage.
(A) Cells were transfected with the indicated siRNAs, and localized DNA damage was 
induced using a focused laser microbeam. The cells were fixed 15 min or 2 hr later and 
stained with antibodies against γH2AX and K48-Ub. (B) The accumulation of K48-Ub was 
quantified according to the fluorescence intensity obtained using the corresponding antibody 
on top of γH2AX stripes. The immunoblot shows the extent of UBE4A depletion in tis 
experiment. (C) K48-Ub lines were classified as ‘strong’, ‘average’ or ‘weak/undetectable’. 
(D-F) Similar analysis as in (A-C) for K63-linked ubiquitin chains. AU - arbitrary units. 
Quantified data in B and C are represented as mean ± SEM (3 independent experiments, 
n>70), and in E and F as mean ± SEM (4 independent experiments, n>80). *p<0.05, ** 
p<0.005, *** p-<0.0005 (student's t-test, relative to the siCTRL). (See also Figures S6 and 
S7).
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Figure 5. UBE4A is required for assembly of ubiquitin-dependent factors at sites of DNA 
damage, in a U-box-dependent manner.
(A) U2-OS cells were transfected with the indicated siRNA, treated with 20 ng/ml of NCS, 
and stained for nuclear foci of RAP80 at the indicated time points. (B) U2-OS cells were 
transfected with irrelevant or siRNA against UBE4A, as well as constructs expressing 
siRNA-resistant wild-type GFP-UBE4A or GFP-UBE4A(ΔU-box). 48 hr later the cells were 
treated with 20 ng/ml of NCS and stained for nuclear foci of RAP80. (C) U2-OS cell were 
transfected with the indicated siRNA, treated with 20 ng/ml of NCS, and stained for nuclear 
foci of BRCA1 and cyclin-A2 at the indicated time points. BRCA1 foci were quantified in 
cyclin-A2-positive cells (i.e., cells at the S and G2 phases of the cell cycle). (D) U2-OS cell 
transfected with the indicated siRNA, treated with 1 Gy of IR, and 1 hr later stained for 
RAD51 and cyclin A2. Shown are percentages of cyclin A2-positive cells with more than 10 
RAD51 foci/cell. Quantified data represented as mean ± SEM (2 independent experiments, 
n>100, except in (E) where mean ± SD is shown (3 independent experiments, n>600). 
*p<0.05. ***p<0.0001 (student’s t-test). UT: untreated. Images in (A) and (C) were captured 
and analyzed using the Hermes WIScan apparatus. Images in (B) were captured using 
conventional fluorescence microscopy and analyzed using ImageJ software. Quantified data 
are presented as mean ± SEM [2 independent experiments, n>2000, in (A) and (C), and 2 
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independent experiments, n=100 in (B)]. **p<0.005, ***p<0.0005 (student’s t-test, relative 
to the siCTRL).
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Figure 6. UBE4A affects focus organization at sites of DNA damage.
(A) Conventional diffraction limited total internal reflection fluorescence (TIRF) microscope 
image of γH2AX and RAP80. Merged image with cutaway super-resolution (SR) revealing 
the improved resolution. Lower panel: Selected zoomed regions showing γH2AX/RAP80 
foci. (B) Representative image of the overlaps of RAD51/PALB2/γH2AX foci particles in 
cells treated with control or UBE4A siRNAs and treated with NCS for 30 min. (C) 
Quantification of the average area of focus particles (denoted as ‘cluster size’) of various 
DDR proteins in cells treated with control or UBE4A siRNA and subsequently treated with 
NCS for 30 min. (D) Quantification of the number of overlaps per nucleus (normalized to 
the total number of particles detected) between different pairs of DDR factors. (E) 
Quantification of the extent of overlap between various DDR factors in cells treated with 
control or UBE4A siRNA and subsequently treated with NCS for 30 min. (F) Molecular 
model for the role of UBE4A in ubiquitin signal enhancement. (1) The ubiquitin E3 ligases, 
RNF8 and RNF168, are recruited to DSB sites and mediate protein ubiquitylation. (2) 
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UBE4A is recruited in a 53BP1-dependent manner and regulates further adjustment of K48- 
and K63-linked ubiquitin chains. The dotted lines indicate physical interaction that may be 
mediated by other proteins. (3) RAP80 is recruited to K63-Ub, thereby recruiting BRCA1 to 
form the BRCA1-A complex. (4) UBE4A promotes the dynamic reorganization of the 
BRCA1-A complex into the BRCC complex, which in turn promotes RAD51 recruitment 
and HRR. (See also Figure S8).
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Figure 7. UBE4A depletion interferes with the balance between DSB repair pathways.
(A) HRR measurement based on the DR-GFP assay (Pierce et al., 2001). The siUBE4A pool 
includes four siRNA sequences: siRNAs #1 to siRNA #4. Cells transfected with irrelevant 
siRNA or siRNA against RAD51 – a major HRR protein – served as controls. (B) CRISPR-
mediated HDR. The CRISPR clover-LMNA HDR assay (Pinder et al., 2015) was conducted 
in U2-OS cells in triplicate (n= 500-750 cells per replicate) and error bars = SEM. **p<0.03, 
***p<0.001 (Student's t-test). The blots show the extent of protein depletion in this 
experiment. (See also Figure S7). (C-E) C-NHEJ, alt-NHEJ and SSA measured using the 
EJ5-GFP, EJ2-GFP and SA-GFP reporters (Bennardo et al., 2008), respectively. In all cases, 
repair of an I-SceI meganuclease-induced DSB renders the cells GFP positive when repair is 
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achieved via the indicated pathway. The efficiency of repair was calculated as the percentage 
of GFP positive cells in response to I-SceI expression upon downregulation of the indicated 
genes, normalized against the control. The average and standard deviation of at least three 
independent experiments is shown. (F) End-resection measured using the SMART assay 
(Cruz-Garcia et al., 2014). Median resection length was measured one hour after exposing 
cells transfected with the indicated siRNAs to 10 Gy of IR. The average and standard 
deviation of four independent experiments is shown. For each replica, at least 300 individual 
ssDNA fibers were measured. *p<0.05, **p<0.005. (G) A model scheme showing the role 
of UBE4A-mediated modulation of protein ubiquitylation in pathway choice during DSB 
repair.
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